These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22911633)

  • 1. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.
    Chen WD; Yu D; Forman BM; Huang W; Wang YD
    Hepatology; 2013 Feb; 57(2):656-66. PubMed ID: 22911633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
    Guo C; Su J; Li Z; Xiao R; Wen J; Li Y; Zhang M; Zhang X; Yu D; Huang W; Chen WD; Wang YD
    Oncotarget; 2015 Oct; 6(33):34402-13. PubMed ID: 26417930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways.
    Su J; Zhang Q; Qi H; Wu L; Li Y; Yu D; Huang W; Chen WD; Wang YD
    Oncotarget; 2017 Aug; 8(33):54378-54387. PubMed ID: 28903349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
    Guo C; Qi H; Yu Y; Zhang Q; Su J; Yu D; Huang W; Chen WD; Wang YD
    Front Pharmacol; 2015; 6():287. PubMed ID: 26696888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
    Wang YD; Chen WD; Yu D; Forman BM; Huang W
    Hepatology; 2011 Oct; 54(4):1421-32. PubMed ID: 21735468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle?
    Péan N; Doignon I; Tordjmann T
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):226-9. PubMed ID: 23434440
    [No Abstract]   [Full Text] [Related]  

  • 7. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Liu X; Chen B; You W; Xue S; Qin H; Jiang H
    Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.
    Rao J; Yang C; Yang S; Lu H; Hu Y; Lu L; Cheng F; Wang X
    Int Immunol; 2020 May; 32(5):321-334. PubMed ID: 31930324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
    Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
    Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
    Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells.
    Lou G; Ma X; Fu X; Meng Z; Zhang W; Wang YD; Van Ness C; Yu D; Xu R; Huang W
    PLoS One; 2014; 9(4):e93567. PubMed ID: 24755711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
    Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
    Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
    Qi Y; Duan G; Wei D; Zhao C; Ma Y
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 activation in monocytes accelerates liver cancer progression.
    Wu WY; Li J; Wu ZS; Zhang CL; Meng XL
    BMC Cancer; 2011 Dec; 11():506. PubMed ID: 22136659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy.
    Xiao H; Sun X; Liu R; Chen Z; Lin Z; Yang Y; Zhang M; Liu P; Quan S; Huang H
    Pharmacol Res; 2020 Jan; 151():104559. PubMed ID: 31759089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
    Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
    World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
    Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
    J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
    Reich M; Deutschmann K; Sommerfeld A; Klindt C; Kluge S; Kubitz R; Ullmer C; Knoefel WT; Herebian D; Mayatepek E; Häussinger D; Keitel V
    Gut; 2016 Mar; 65(3):487-501. PubMed ID: 26420419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.
    Seo EB; Jang HJ; Kwon SH; Kwon YJ; Kim SK; Lee SH; Jeong AJ; Shin HM; Kim YN; Ma S; Kim H; Lee YH; Suh PG; Ye SK
    Hepatol Commun; 2022 Nov; 6(11):3234-3246. PubMed ID: 36153805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.